This article reviews the utility of magnetic resonance imaging (MRI)/magnetic resonance venography (MRV) in the assessment of common venous problems. There is a brief synopsis of current MRI/MRV techniques used for such purposes. This is followed by a review of application of these techniques to specific diagnoses. In short, MRV is quite useful for assessing venous pathology.
Wehrli FWIntroduction to Fast Scan Magnetic Resonance. Milwaukee, WI: General Electric Medical Systems; 1986.
12.
Wehrli FW, Shimakawa A., Gullberg GT, Macfall JRTime-of-flight MR flow imaging-selective saturation recovery with gradient refocusing. Radiology. 1986;160:781-785.
13.
Crooks LE, Mills CM, Davis PL, et al. Visualization of cerebral and vascular abnormalities by NMR imaging-the effects of imaging parameters on contrast. Radiology . 1982;144:843-852.
14.
Perman WH, Moran PR, Moran RA, Bernstein MAArtifacts from pulsatile flow in MR imaging. J Comput Assist Tomogr. 1986;10:473-483.
15.
Spritzer CE , Blinder RAPractical aspects of vascular imaging using MRI. Crit Rev Diagn Imaging. 1990;31: 145-185.
16.
Frahm J., Merboldt KD, Hanicke W., Haase A.Flow suppression in rapid flash NMR images. Magn Reson Med . 1987;4:372-377.
17.
Oppelt A., Graumann R., Barfuss H., Fischer H., Hartl W., Schajor W.Fast imaging with steady precession a new fast magnetic resonance imaging sequence. Electromedica. 1986;54:15-18.
18.
Totterman S. , Francis CW, Foster TH, Brenner B., Marder VJ, Bryant RGDiagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. AJR Am J Roentgenol. 1990; 154: 175-178.
19.
Wedeen V.Magnetic Resonance Annual. New York, NY: Raven Press; 1987.
20.
Caputo GR, Kondo C., Higgins CBMagnetic resonance angiography and blood flow quantification. Am J Card Imaging. 1993;7:233-242.
21.
Pelc NJFlow quantification and analysis methods. Magn Reson Imaging Clin N Am. 1995;3:413-424.
22.
Pelc NJ, Herfkens RJ, Shimakawa A., Enzmann DRPhase contrast cine magnetic resonance imaging. Magn Res Q . 1991;7:229-254.
23.
Fraser DGW , Moody AR, Morgan PS, Martel AL, Davidson I.Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging . Ann Intern Med. 2002;136: 89-98.
Fowkes FJI , Price JF, Fowkes Fgr.Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003;25:1-5.
28.
Tapson VFAcute pulmonary embolism. N Engl J Med. 2008 ;358:1037-1052.
29.
Spritzer CE , Sostman HD, Wilkes DC, Coleman REDeep venous thrombosis-experience with gradient-echo MR imaging in 66 patients. Radiology. 1990 ;177:235-241.
30.
Spritzer CE , Norconk JJ, Sostman HD, Coleman REDetection of deep venous thrombosis by magnetic-resonance-imaging . Chest . 1993;104:54-60.
31.
Evans AJ, Sostman HD, Knelson MH, et al. Detection of deep venous thrombosis-prospective comparison of MR-imaging with contrast venography. AJR Am J Roentgenol. 1993;161:131-139.
32.
Erdman WA, Jayson HT, Redman HC, Miller GL, Parkey RW, Peshock RWDeep venous thrombosis of extremities: role of MR imaging in the diagnosis . Radiology. 1990;174:425-431.
33.
Sampson FC, Goodacre SW, Thomas SM, van Beek EJThe accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol. 2007 ;17:175-181.
34.
Li W., Salanitri J., Tutton S., et al. Lower extremity deep venous thrombosis: evaluation with ferumoxytolenhanced MR imaging and dual-contrast mechanism- preliminary experience. Radiology. 2007;242: 873-881.
35.
Spuentrup E. , Botnar RM, Wiethoff AJ, et al. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol. 2008; 18:1995-2005.
36.
Lund F., Diener L., Ericsson JLPostmortem intraosseous phlebography as an aid in studies of venous thromboembolism-with application on a geriatric clientele. Angiology. 1969;20:155-176.
37.
Cronan JJVenous thromboembolic disease-the role of US. Radiology . 1993;186:619-630.
38.
Vaccaro JP, Cronan JJ, Dorfman GSOutcome analysis of patients with normal compression US examinations . Radiology. 1990;175:645-649.
39.
Spritzer CE , Arata MA, Freed KSIsolated pelvic deep venous thrombosis: relative frequency as detected with MR imaging. Radiology. 2001;219:521-525.
40.
Nicolaid AN , Kakkar VV, Field ES, Renney JTG.Origin of deep vein thrombosis-venographic study. Br J Radiol. 1971;44:653-663.
41.
Stamatakis JD, Kakkar VV, Lawrence D., Bentley PGOrigin of thrombi in deep veins of lower limb: a venographic study. Br J Surg . 1978;65:449-451.
42.
Montgomery K., Potter H., Helfet D.Magnetic resonance venography to evaluate the deep venous system of the pelvis in patients who have an acetabular fracture . J Bone Joint Surg Am. 1995;77:1639-1649.
43.
Bertsch NM, Mastrobattista JM, Kawashima A., Kramer LAAntepartum bilateral ovarian vein thrombosis: magnetic resonance imaging diagnosis . Am J Perinatol. 1997; 14:597-599.
44.
Kubik-Huch RA, Hebisch G., Huch R., Hilfiker P., Debatin JF, Krestin GPRole of duplex color Doppler ultrasound, computed tomography, and MR angiography in the diagnosis of septic puerperal ovarian vein thrombosis. Abdom Imaging . 1999;24:85-91.
45.
Maharaj D.Puerperal pyrexia: a review. Part II. Obstet Gynecol Surv . 2007;62:400-406.
46.
Twickler DM , Setiawan AT, Evans RS, et al. Imaging of puerperal septic thrombophlebitis: prospective comparison of MR imaging, CT, and sonography. AJR Am J Roentgenol. 1997 ;169:1039-1043.
47.
Cramer SC, Rordorf G., Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study . Stroke. 2004;35:46-50.
Cramer SC, Maki JH, Waitches GM, et al. Paradoxical emboli from calf and pelvic veins in cryptogenic stroke. J Neuroimaging. 2003;13:218-223.
50.
Parellada AJ , Morrison WB, Reiter SB, et al. Unsuspected lower extremity deep venous thrombosis simulating musculoskeletal pathology. Skeletal Radiol. 2006;35:659-664.
51.
Erdman WA, Parkey RWMR imaging of deep venous thrombosis. AJR Am J Roentgenol . 1990;155:897.
52.
Spritzer CE , Trotter P., Sostman HDDeep venous thrombosis: gradient-recalled-echo MR imaging changes over time-experience in 10 patients. Radiology . 1998;208: 631-639.
53.
Tempany CM, Morton RA, Marshall FFMRI of the renal veins: assessment of nonneoplastic venous thrombosis . J Comput Assist Tomogr. 1992;16:929-934.
54.
Hansen M., Spritzer C., Sostman H.Assessing the patency of mediastinal and thoracic inlet veins: value of MR imaging. AJR Am J Roentgenol. 1990;155:1177-1182.
55.
Finn J., Zisk J., Edelman R., et al. Central venous occlusion: MR angiography. Radiology . 1993;187:245-251.
56.
Shinde TS, Lee VS, Rofsky NM, Krinsky GA, Weinreb JCThree-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience. Radiology . 1999;213: 555-560.
57.
Tanju S., Sancak T., Dusunceli E., Yagmurlu B., Erden I., Sanlidilek U.Direct contrast-enhanced 3D MR venography evaluation of upper extremity deep venous system. Diagn Interv Radiol. 2006 ;12:74-79.
58.
Thornton MJ , Ryan R., Varghese JC, Farrell MA, Lucey B., Lee MJA three-dimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol . 1999;173:999-1003.
59.
Prince MR, Arnoldus C., Frisoli JKNephrotoxicity of high-dose gadolinium compared with iodinated contrast . JMRI J Magn Reson Imaging. 1996;6:162-166.
60.
Tombach B., Bremer C., Reimer P., et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology. 2001;218:651-657.
61.
Sam AD, Morasch MD, Collins J., Song G., Chen R., Pereles FSSafety of gadolinium contrast angiography in patients with chronic renal insufficiency . J Vasc Surg. 2003;38:313-318.
62.
Khurram M., Skov L., Rossen K., Thomsen HS, Marckmann P.Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients. Scand J Urol Nephrol. 2007 ;41:565-566.
63.
Marckmann P. , Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17: 2359-2362.
64.
Marckmann P. , Skov L., Rossen K., Heaf JG, Thomsen HSCase-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dialy Transplant. 2007; 22:3174-3178.
65.
Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S., LeBoit PEScleromyxoedema-like cutaneous diseases in renal-dialysis patients . Lancet. 2000;356234): 1000-1001.
66.
US Food and Drug Administration.Public Health Advisory.Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Omniscan, OptiMARK, Magnevist, ProHance, and MultiHance. Rockville, MD: US Food and Drug Administration;2006.
67.
Sadowski EA , Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-157.
68.
Kim CY, Mirza RA, Bryant JA, et al. Central veins of the chest: evaluation with time-resolved MR angiography. Radiology. 2008;247:558-566.
69.
Pedrosa I., Morrin M., Oleaga L., Baptista J., Rofsky NMIs true FISP imaging reliable in the evaluation of venous thrombosis ? AJR Am J Roentgenol. 2005;185: 1632-1640.
